100
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor

&
Pages 1659-1666 | Published online: 20 Apr 2021

References

  • Katz G, Levkovitch-Verbin H, Treister G, Belkin M, Ilany J, Polat U. Mesopic foveal contrast sensitivity is impaired in diabetic patients without retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248(12):1699–1703. doi:10.1007/s00417-010-1413-y
  • Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103(1):51–54. doi:10.1001/archopht.1985.01050010055018
  • Falsini B, Porciatti V, Scalia G, et al. Steady-state pattern electroretinogram in insulin dependent diabetics with no or minimal retinopathy. Doc Ophthalmol. 1989;73(2):193–200. doi:10.1007/BF00155037
  • Greenstein V, Sarter B, Hood D, Noble K, Carr R. Hue discrimination and cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1990;31:1008–1014.
  • Hegazy AI, Zedan RH, Macky TA, Esmat SM. Retinal ganglion cell complex changes using spectral domain optical coherence tomography in diabetic patients without retinopathy. Int J Ophthalmol. 2017;10(3):427. doi:10.18240/ijo.2017.03.16
  • Varma R, Bressler NM, Suñer I, et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology. 2012;119(10):2108–2118. doi:10.1016/j.ophtha.2012.05.017
  • Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):5–14. doi:10.1016/j.ophtha.2011.09.058
  • Baker CW, Glassman AR, Beaulieu WT, et al. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial. JAMA. 2019;321(19):1880–1894. doi:10.1001/jama.2019.5790
  • Gruber N, Mosimann UP, Muri RM, Nef T. Vision and night driving abilities of the elderly. Traffic Inj Prev. 2013;14(5):477–485. doi:10.1080/15389588.2012.727510
  • Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122(7):1375–1394. doi:10.1016/j.ophtha.2015.03.024
  • Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res. 2014;41:1–25. doi:10.1016/j.preteyeres.2014.04.001
  • Ou WC, Brown DM, Payne JF, Wykoff CC. Relationship between visual acuity and retinal thickness during anti–vascular endothelial growth factor therapy for retinal diseases. Am J Ophthalmol. 2017;180:8–17. doi:10.1016/j.ajo.2017.05.014
  • Nieves-Moreno M, Martínez-de-la-casa JM, Cifuentes-Canorea P, et al. Normative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population. PLoS One. 2017;12(7):e0180450. doi:10.1371/journal.pone.0180450
  • Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2:187–99.37.
  • Elliott DB, Bullimore MA, Bailey IL. Improving the reliability of the Pelli-Robson contrast sensitivity test. Clin Vis Sci. 1991;6:471–475.
  • Griffin A, Cheng H, Robson J. Measuring contrast sensitivity using CambBlobs2 disposable paper charts in normal subjects. Invest Ophthalmol Vis Sci. 2017.
  • Robson J, Raman R, Jaisankar D, Sapkota RP, Pardhan S. Contrast sensitivity measured with illiterate single use printed paper charts to assess the severity of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017.
  • Canadian Medical Association. Section 12: Vision. Canadian Medical Association Driver’s Guide. 8th ed. Toronto: Canadian Medical Association; 2012:48–52.
  • Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K. Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol. 2017;178:129–139. doi:10.1016/j.ajo.2017.03.019
  • Ronnie G, Hemamalini A, Baskaran M, Ramesh SV, Raju P, Vijaya L. The Chennai glaucoma study: prevalence and risk factors for glaucoma in cataract operated eyes in urban Chennai Indian. J Ophthalmol. 2010;58(3):243–245.
  • West SK, Rubin GS, Bowman AT, Munoz B, Bandeen-Roche K, Turano K. How does visual impairment affect performance on tasks of everyday life? The SEE project. Arch Ophthalmol. 2002;120(6):774–780. doi:10.1001/archopht.120.6.774
  • Rubin GS, Bandeen-Roche K, Huang GH, et al. The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci. 2001;42:64–72.
  • van Dijk HW, Verbraak FD, Kok PH, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2010;51(7):3660–3665. doi:10.1167/iovs.09-5041
  • Stavrou EP, Wood JM. Letter contrast sensitivity changes in early diabetic retinopathy. Clin Exp Optom. 2003;86(3):152–156. doi:10.1111/j.1444-0938.2003.tb03097.x
  • Nixon DR, Flinn NA. Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab. Clin Ophthalmol. 2018;12:191–197. doi:10.2147/OPTH.S158268
  • Owsley C, Sekuler R, Siemsen D. Contrast sensitivity throughout adulthood. Vision Res. 1983;23(7):689–699. doi:10.1016/0042-6989(83)90210-9